July 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreFebruary 10, 2026
Market insights predict the global herbal supplement for mental health industry will increase from USD 15.04 billion in 2025 to USD 29.7 billion by 2035, achieving a CAGR of 7.04%. The rising prevalence of mental disorders and the growing demand for nutraceuticals drive the global market. North America dominated the market due to the presence of ke...
February 10, 2026
Based on our forecasts, the iPSC cell therapies market was valued at USD 10.44 billion in 2025 and is expected to reach USD 11.64 billion by 2026, growing steadily to approximately USD 30.87 billion by 2035 at a CAGR of 11.45% during the forecast period....
February 10, 2026
According to our insight calculates, the membrane technology in the pharmaceutical market was valued at USD 2.66 billion in 2026 and is projected to reach USD 4.43 billion by 2035, growing at a CAGR of 5.85% from 2026 to 2035....
February 10, 2026
Based on our research, the drug product development service market was valued at USD 340.04 million in 2025 and is projected to reach USD 350.38 million in 2026, expanding further to USD 458.76 million by 2035 at a CAGR of 3.04%....
February 09, 2026
The global single-use bioreactors market, valued at USD 5.38 billion in 2025, is anticipated to reach USD 26.33 billion by 2035, growing at a CAGR of 17.21% over the next decade. In 2024, North America led the single-use bioreactors market (35%), with Asia Pacific set for rapid growth. SUB systems and stirred tank types dominated, while single-use ...
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segments, regional distribution (NA, EU, APAC, LA, MEA), manufacturer data, competitive benchmarking, value...
February 09, 2026
The global GMP drug substance market was USD 2.71 billion in 2025 and is projected to reach USD 4.91 billion by 2035 at a CAGR of 6.14%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads, with Asia-Pacific growing fastest. The market features top players like AGC Biologics, Catalent, an...
February 09, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
February 09, 2026
According to our forecasts, the clinical endpoint adjudication (CEA) market was valued at USD 0.97 billion in 2025 and is projected to grow from USD 1.05 billion in 2026 to USD 2.23 billion by 2035, expanding at a CAGR of 8.66%....
February 06, 2026
The U.S. pharmaceutical CDMO market size is calculated at USD 39.13 bn in 2025 is to hit USD 72.98 bn by 2035. The U.S. Pharmaceutical CDMO market is evolving with key developments in 2024. Recipharm partnered with Exela Pharma for sterile manufacturing, Agilent acquired Biovectra for $925M to expand its CDMO capabilities, and Thermo Fisher's bioph...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
